Well-D Capsule contains a combination of Domperidone 30mg and Pantoprazole 40mg, formulated to manage gastrointestinal disorders associated with acid reflux and delayed gastric emptying. Domperidone is a dopamine antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, effectively reducing gastric acidity and promoting mucosal healing in conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of these two agents provides symptomatic relief from heartburn, acid regurgitation, and dyspepsia while improving gastric motility. Well-D Capsule is indicated for patients suffering from GERD with associated motility disorders and is typically administered orally once daily before meals. Caution is advised in patients with known hypersensitivity to any component, and it should be used under medical supervision, especially in those with hepatic or renal impairment. Adverse effects may include headache, dry mouth, or gastrointestinal disturbances, and drug interactions should be carefully considered prior to therapy initiation.